Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010

Kirkcaldy, Robert D.; Augostini, Peter; Asbel, Lenore E.; Bernstein, Kyle T.; Kerani, Roxanne P.; Mettenbrink, Christie J.; Pathela, Preeti; Schwebke, Jane R.; Secor, W. Evan; Workowski, Kimberly A.; Davis, Darlene; Braxton, Jim; Weinstock, Hillard S.

doi:10.3201/eid1806.111590

Back to Previous Page

Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010

Published Date:

Jun 2012

Publisher's site:

http://dx.doi.org/10.3201/eid1806.111590

Source:

Emerg Infect Dis. 18(6):939-943.

Language:

English

[PDF-333.39 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Kirkcaldy, Robert D. ; Augostini, Peter ; Asbel, Lenore E. ; Bernstein, Kyle T. ; Kerani, Roxanne P. ; ... More ▼

Description:

Nitroimidazoles (metronidazole and tinidazole) are the only recommended drugs for treating Trichomonas vaginalis infection, and previous samples that assessed resistance of such isolates have been limited in geographic scope. We assessed the prevalence of in vitro aerobic metronidazole and tinidazole resistance among T. vaginalis isolates from multiple geographic sites in the United States. Swab specimens were obtained from women who underwent routine pelvic examinations at sexually transmitted disease clinics in 6 US cities. Cultured T. vaginalis isolates were tested for nitroimidazole resistance (aerobic minimum lethal concentration [MLC] >50 µg/mL). Of 538 T. vaginalis isolates, 23 (4.3%) exhibited low-level in vitro metronidazole resistance (minimum lethal concentrations 50-100 µg/mL). No isolates exhibited moderate- to high-level metronidazole resistance or tinidazole resistance. Results highlight the possibility that reliance on a single class of antimicrobial drugs for treating T. vaginalis infections may heighten vulnerability to emergence of resistance. Thus, novel treatment options are needed.

Subject:

[+]

Document Type:

Journal Article

Funding:

PS08-865/PS/NCHHSTP CDC HHS/United States

Place as Subject:

United States

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

File Type:

Supporting Files:

	11-1590-F.gif	image/gif
	11-1590-F.jpg	image/jpeg
	11-1590_finalR.nxml	text/plain
	license.txt	text/plain

No Related Documents.

Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA

[PDF - 507.27 KB]

Personal Author:

Papp, John R. ; Abrams, A. Jeanine ; ...

Published Date:

May 2017

Source:

Emerg Infect Dis. 23(5):830-832.

Description:

During 2016, eight Neisseria gonorrhoeae isolates from 7 patients in Hawaii were resistant to azithromycin; 5 had decreased in vitro susceptibility to...

File Type:

[PDF - 507.27 KB]

File Type:

[PDF - 507.27 KB]
Combatting the treat of antibiotic-resistant gonorrhea

[PDF - 416.87 KB]

Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.

Published Date:

Revised August 9, 2017

Description:

Antibiotic resistance is the ability of bacteria to resist the e ects of drug treatment. Simply put, germs continue to multiply because the drugs cann...

File Type:

[PDF - 416.87 KB]

File Type:

[PDF - 416.87 KB]
Antimicrobial Drug Resistance in Peru

[PDF - 139.15 KB]

Personal Author:

García, Coralith ; Horna, Gertrudis ; ...

Published Date:

Mar 2012

Source:

Emerg Infect Dis. 18(3):520-521.

File Type:

[PDF - 139.15 KB]

File Type:

[PDF - 139.15 KB]
Macrolide-Resistant Mycoplasma pneumoniae, United States1

[PDF - 574.09 KB]

Personal Author:

Zheng, Xiaotian ; Lee, Stella ; ...

Published Date:

Aug 2015

Source:

Emerg Infect Dis. 21(8):1470-1472.

Description:

Macrolide-resistant Mycoplasma pneumoniae (MRMP) is highly prevalent in Asia and is now being reported from Europe. Few data on MRMP are available in ...

File Type:

[PDF - 574.09 KB]

File Type:

[PDF - 574.09 KB]
The first year of the global Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) in Bangkok, Thailand, 2015-2016

[PDF - 805.99 KB]

Personal Author:

Sirivongrangson, Pachara ; Girdthep, Natnaree ; ...

Corporate Authors:

EGASP Thailand Workgroup

Published Date:

November 09 2018

Source:

PLoS One. 13(11)

Description:

Antimicrobial-resistant Neisseria gonorrhoeae (NG) infection is a global public health threat, and there is a critical need to monitor patterns of res...

File Type:

[PDF - 805.99 KB]

File Type:

[PDF - 805.99 KB]

Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010

Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC